Approval · Notice of Compliance 9292 · 2008
METOJECT: Notice of Compliance 9292
Issued January 11, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9292
- Date
- January 11, 2008
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antimetabolite and antirheumatic
- Canadian reference product
- METHOTREXATE INJECTION (Mayne Pharma (Canada) Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METOJECT | 02304767 | Cancelled Post Market |
Medicinal ingredients
- METHOTREXATE SODIUM 10 MG per ML